Could lower blood thinner doses make ECMO safer?
NCT ID NCT07499037
First seen Apr 07, 2026 · Last updated Apr 25, 2026 · Updated 2 times
Summary
This study tests whether lower doses of two blood thinners (argatroban and enoxaparin) can reduce bleeding and clotting problems in adults on ECMO, a machine that helps the heart and lungs. About 200 participants with pneumonia or heart failure will be enrolled. The goal is to find a safer way to manage blood thinning during this life support.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Motol
Prague, 150 00, Czechia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, 708 52, Czechia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.